EX-23.1 9 adro-ex231_1323.htm EX-23.1 adro-ex231_1323.htm

Exhibit 23.1

CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM

We consent to the incorporation by reference in Registration Statement Nos. 333-203508, 333-210016, 333-216373, 333-223382 and 333-229915 on Form S-8 and Registration Statement Nos. 333-219639 and 333-219640 on Form S-3 of our report dated March 9, 2020, relating to the consolidated financial statements of Aduro Biotech, Inc. and subsidiaries (the “Company”) appearing in this Annual Report on Form 10-K of the Company for the year ended December 31, 2019.

 

/s/ Deloitte & Touche LLP
San Francisco, California

March 9, 2020